Conference report - global vaccines - what are the challenges? Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.
Armandola
Elena
E
European Patent Office, Munich, Germany.
D000284:Administration, Oral; D002675:Child, Preschool; D003695:Delivery of Health Care / Q000592:standards / Q000706:statistics & numerical data / Q000639:trends; D003906:Developing Countries / Q000191:economics; D006801:Humans; D017589:Immunization Programs / Q000191:economics / Q000706:statistics & numerical data* / Q000600:supply & distribution / Q000639:trends*; D007223:Infant; D007231:Infant, Newborn; D012106:Research / Q000191:economics / Q000592:standards / Q000639:trends; D012401:Rotavirus / Q000276:immunology; D012400:Rotavirus Infections / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use; D014765:Viral Vaccines / Q000009:adverse effects / Q000191:economics / Q000378:metabolism / Q000600:supply & distribution
D022243:Rotavirus Vaccines; D014765:Viral Vaccines